5 Results for "

HER2-IN-8

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "HER2-IN-8" in MCE Product Catalog:

Cat. No.: HY-144097
CAS No.: 2704630-49-7
Target:  

EGFR

Research Areas:  

Inflammation/Immunology Cancer

HER2-IN-8 is a HER-2 inhibitor extracted from patent WO2021179274A1 compound 107. HER2-IN-8 can be used for the research of cancer and inflammation .
loading...
    loading...
Cat. No.: HY-145960
CAS No.: 2413016-49-4
Research Areas:  

Inflammation/Immunology

MC-Val-Cit-PAB-Amide-TLR7 agonist 4 (example 15) is a HER2-TLR7 and HER2-TLR8 immune agonist conjugate .
loading...
    loading...
Cat. No.: HY-151161
CAS No.: 2820126-32-5
Target:  

EGFR

Research Areas:  

Cancer

EGFR/HER2-IN-8 (compound 34) is a EGFR/HER2 and DHFR inhibitor. EGFR/HER2-IN-8 inhibits EGFR kinase, HER2 kinase and DHFR with IC50s of 0.45, 0.244 and 5.669 μM, respectively. EGFR/HER2-IN-8 shows anticancer activity against several cancer cell lines with high safety profile and selectivity indices. EGFR/HER2-IN-8 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-145960A
Research Areas:  

Inflammation/Immunology

MC-Val-Cit-PAB-Amide-TLR7 agonist 4 formic (example 15) is a HER2-TLR7 and HER2-TLR8 immune agonist conjugate .
loading...
    loading...
Cat. No.: HY-151156
CAS No.: 2820126-50-7
Target:  

EGFR Apoptosis

Research Areas:  

Cancer

EGFR/HER2-IN-6 (compound 43) is an EGFR/HER2 and DHFR inhibitor. EGFR/HER2-IN-6 inhibits EGFR kinase, HER2 kinase and DHFR with IC50s of 0.122, 0.078 and 0.585 μM, respectively. EGFR/HER2-IN-6 shows anticancer activity against several cancer cell lines with high safety profile and selectivity indices. EGFR/HER2-IN-8 can be used for the research of cancer .
loading...
    loading...